There are many AS events involves in EMT during cancer progression, such as splicing of FGFR2, CD44, CTNND1, and ENAH and they may become therapeutic points- it is therefore timely to ask ourselves: Can these AS events in EMT be targets of cancer therapy? This evidence concerns the gene ENAH and cancer.